Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 128 Records) |
Query Trace: NR1I2[original query] |
---|
Genetic Polymorphisms and Adverse Events on Unbound Imatinib and Its Active Metabolite Concentration in Patients With Gastrointestinal Stromal Tumors. Frontiers in pharmacology 2019 10 854. Qian Yi, Sun Lu-Ning, Liu Yang-Jie, Zhang Qiang, Xu Jiang-Hao, Ma Zeng-Qing, Zhang Xue-Hui, Xu Hao, Wang Yong-Qi |
Impact of NR1I2, adenosine triphosphate-binding cassette transporters genetic polymorphisms on the pharmacokinetics of ginsenoside compound K in healthy Chinese volunteers. Journal of ginseng research 2019 Jul 43 (3): 460-474. Zhou Luping, Chen Lulu, Wang Yaqin, Huang Jie, Yang Guoping, Tan Zhirong, Wang Yicheng, Liao Jianwei, Zhou Gan, Hu Kai, Li Zhenyu, Ouyang Dongshe |
Effect of patient genetics on etonogestrel pharmacokinetics when combined with efavirenz or nevirapine ART. The Journal of antimicrobial chemotherapy 2019 Jul . Neary Megan, Chappell Catherine A, Scarsi Kimberly K, Nakalema Shadia, Matovu Joshua, Achilles Sharon L, Chen Beatrice A, Siccardi Marco, Owen Andrew, Lamorde Mohamm |
Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI. Frontiers in oncology 2019 9 1312. De Mattia Elena, Polesel Jerry, Roncato Rossana, Labriet Adrien, Bignucolo Alessia, Dreussi Eva, Romanato Loredana, Guardascione Michela, Buonadonna Angela, D'Andrea Mario, Lévesque Eric, Jonker Derek, Couture Félix, Guillemette Chantal, Cecchin Erika, Toffoli Giusep |
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial. The Journal of antimicrobial chemotherapy 2019 Nov . Dickinson Laura, Gurjar Rohan, Stöhr Wolfgang, Bonora Stefano, Owen Andrew, D'Avolio Antonio, Cursley Adam, Molina Jean-Michel, Fäetkenheuer Gerd, Vandekerckhove Linos, Di Perri Giovanni, Pozniak Anton, Richert Laura, Raffi François, Boffito Marta, |
Association between NR1I2 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population: A case-control study. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2020 May 83 104349. Yang Miaomiao, Pan Hongqiu, Chen Hongbo, Liu Wenpei, Lu Lihuan, He Xiaomin, Yi Honggang, Tang Shaow |
Genetic influence of ABCG2, UGT1A1 and NR1I2 on dolutegravir plasma pharmacokinetics. The Journal of antimicrobial chemotherapy 2020 Feb . Elliot Emilie R, Neary Megan, Else Laura, Khoo Saye, Moyle Graeme, Carr Daniel F, Wang Xinzhu, Mcclure Myra, Boffito Marta, Owen Andr |
Clopidogrel responder status is uninfluenced by CYP2C19*2 in Danish patients with stroke. PloS one 2020 15 (12): e0236260. Rath Charlotte Lützhøft, Jørgensen Niklas Rye, Wienecke Troe |
NR1I2 genetic polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity: A systematic review and meta-analysis. Pharmacology research & perspectives 2020 Dec 8 (6): e00696. Yang Miaomiao, Qiu Yunliang, Jin Yanyu, Liu Wenpei, Wang Qingliang, Yi Honggang, Tang Shaow |
Pharmacogenetics and pharmacokinetics modeling of unexpected and extremely severe toxicities after sorafenib intake. Pharmacogenomics 2020 1 21 (3): 173-179. Ba Hai le, Mbatchi Litaty, Gattacceca Florence, Evrard Alexandre, Lacarelle Bruno, Blanchet Benoit, Ciccolini Joseph, Salas Sébasti |
Polymorphisms at CYP enzymes, NR1I2 and NR1I3 in association with virologic response to antiretroviral therapy in Brazilian HIV-positive individuals. The pharmacogenomics journal 2021 9 22 (1): 33-38. de Almeida Velozo Camila, de Almeida Tailah Bernardo, de Azevedo Marcelo Costa Velho Mendes, Espasandin Isabela, da Cunha Pinto Jorge Francisco, López Sheila, Pizzatti Luciana, Tanuri Amilcar, da Silva Santos Sabrina, Ribeiro-Alves Marcelo, Cardoso Cynthia Chest |
Effects of Postoperative Day and NR1I2 on Tacrolimus Clearance in Chinese Liver Transplant Recipients-A Population Model Approach. Clinical pharmacology in drug development 2021 6 10 (11): 1385-1394. Lu Yanxia, Xu Li, Cui Jianrong, Shen Su, Li Xinga |
The impact of cytochrome P450 3A genetic polymorphisms on tacrolimus pharmacokinetics in ulcerative colitis patients. PloS one 2021 16 (4): e0250597. Furuse Maizumi, Hosomi Shuhei, Nishida Yu, Itani Shigehiro, Nadatani Yuji, Fukunaga Shusei, Otani Koji, Tanaka Fumio, Nagami Yasuaki, Taira Koichi, Kamata Noriko, Watanabe Toshio, Watanabe Kenji, Fujiwara Yasuhi |
Pharmacogenetic predictors of nevirapine pharmacokinetics in Ghanaian children living with HIV with or without TB coinfection. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2021 4 92 104856. Langaee Taimour, Al-Shaer Mohammad H, Gong Yan, Lima Elizabeth, Antwi Sampson, Enimil Anthony, Dompreh Albert, Yang Hongmei, Alghamdi Wael A, Wiesner Lubbe, Peloquin Charles A, Kwara Awewu |
Polymorphisms contribute to differences in the effect of rocuronium in Chinese patients. Basic & clinical pharmacology & toxicology 2021 11 130 (1): 141-150. Zhu Hongyu, Wang Yafeng, Wang Qi, Zhao Shuai, Xu Feng, Hu Zhiqiang, Zhou Ruihui, Huang Shiqian, Han Linlin, Chen Xiangdo |
Genetic diversity of 'Very Important Pharmacogenes' in two South-Asian populations. PeerJ 2021 9 e12294. Bharti Neeraj, Banerjee Ruma, Achalere Archana, Kasibhatla Sunitha Manjari, Joshi Rajend |
Relevance of NR1I2 variants on carbamazepine therapy in Mexican Mestizos with epilepsy at a tertiary-care hospital. Pharmacogenomics 2021 10 22 (15): 983-996. Fricke-Galindo Ingrid, Jung-Cook Helgi, Martínez-Juárez Iris E, Monroy-Jaramillo Nancy, Ortega-Vázquez Alberto, Rojas-Tomé Irma S, Dorado Pedro, Peñas-Lledó Eva, Llerena Adrián, López-López Maris |
Nongenetic and genetic predictors of haemodynamic instability induced by propofol and opioids: A retrospective clinical study. British journal of clinical pharmacology 2022 Aug . Gu Qing-Ling, Xue Fa-Ling, Zheng Zhuo-Ling, Wang Hai-Ni, Guan Yan-Ping, Wen Yong-Zi, Ye Fang, Huang Min, Huang Wen-Qi, Wang Zhong-Xing, Li Jia- |
Relevance of gene polymorphisms of NAT2 and NR1I2 to anti-tuberculosis drug-induced hepatotoxicity. Xenobiotica; the fate of foreign compounds in biological systems 2022 6 52 (5): 520-526. Wang Ning, Guo Shaochen, Liu Haiting, Ding Yangming, Yao Rong, Liu Zhongquan, Zhu Hui, Chen Xi, Yang Xinting, Chen Xiaoyou, Lu |
Constitutive androstane receptor and pregnane X receptor genotype influence efavirenz plasma concentration and CYP2B6 enzyme activity. Scientific reports 2022 Jun 12 (1): 9698. Petros Zelalem, Habtewold Abiy, Makonnen Eyasu, Aklillu Ele |
Germline and somatic genetic variability of oxysterol-related genes in breast cancer patients with early disease of the luminal subtype. Biochimie 2022 Aug 199 158-169. Holý Petr, Hlavá? Viktor, Ostašov Pavel, Brynychová Veronika, Koževnikovová Renata, Trnková Markéta, Kope?ková Kate?ina, M?š?áková So?a, Mrhalová Marcela, Sou?ek Pav |
Nonalcoholic fatty liver disease risk and histologic severity are associated with genetic polymorphisms in children. Hepatology (Baltimore, Md.) 2022 5 77 (1): 197-212. Goyal Nidhi P, Rosenthal Sara B, Nasamran Chanod, Behling Cynthia A, Angeles Jorge E, Fishbein Mark H, Harlow Kathryn E, Jain Ajay K, Molleston Jean P, Newton Kimberly P, Ugalde-Nicalo Patricia, Xanthankos Stavra A, Yates Katherine, Schork Nicholas J, Fisch Kathleen M, Schwimmer Jeffrey B, |
Impact of polymorphisms of pharmacokinetics-related genes and the inflammatory response on the metabolism of voriconazole. Pharmacology research & perspectives 2022 Apr 10 (2): e00935. Aiuchi Naoya, Nakagawa Junichi, Sakuraba Hirotake, Takahata Takenori, Kamata Kosuke, Saito Norihiro, Ueno Kayo, Ishiyama Masahiro, Yamagata Kazufumi, Kayaba Hiroyuki, Niioka Takeno |
Impacts of pregnane X receptor and cytochrome P450 oxidoreductase gene polymorphisms on trough concentrations of apixaban in patients with non-valvular atrial fibrillation. European journal of clinical pharmacology 2022 11 79 (1): 127-135. Nakagawa Junichi, Kinjo Takahiko, Aiuchi Naoya, Ueno Kayo, Tomita Hirofumi, Niioka Takeno |
Effects of NR1I2 and ABCB1 Genetic Polymorphisms on Everolimus Pharmacokinetics in Japanese Renal Transplant Patients. International journal of molecular sciences 2022 10 23 (19): . Yagishita Hironobu, Kagaya Hideaki, Saito Mitsuru, Numakura Kazuyuki, Yamamoto Ryohei, Sagehashi Ryuichiro, Habuchi Tomonori, Satoh Shigeru, Miura Masato |
Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic myeloid leukemia. Frontiers in oncology 2022 12 952640. Madejczyk Anna Marta, Canzian Federico, Góra-Tybor Joanna, Campa Daniele, Sacha Tomasz, Link-Lenczowska Dorota, Florek Izabela, Prejzner Witold, Ca?becka M, Rymko M, Dudzi?ski M, Orzechowska Magdalena Julita, Jamroziak Krzyszt |
Combined impact of hypoalbuminemia and pharmacogenomic variants on voriconazole trough concentration: data from a real-life clinical setting in the Chinese population. Journal of chemotherapy (Florence, Italy) 2023 8 1-11. Yuanyuan Li, Ying Zhang, Jinxia Zhao, Jialu Bian, Yinyu Zhao, Xu Hao, Boyu Liu, Lei Hu, Fang Liu, Changqing Yang, Yufei Feng, Lin Hua |
Effects of polymorphisms in pregnane X receptor and ABC transporters on afatinib in Japanese patients with non-small cell lung cancer: pharmacogenomic-pharmacokinetic and exposure-response analysis. Cancer chemotherapy and pharmacology 2023 7 . Hayato Yokota, Kazuhiro Sato, Sho Sakamoto, Yuji Okuda, Mariko Asano, Masahide Takeda, Katsutoshi Nakayama, Masatomo Miu |
Effect of polymorphisms in drug metabolism and transportation on plasma concentration of atorvastatin and its metabolites in patients with chronic kidney disease. Frontiers in pharmacology 2023 3 14 1102810. Jiang Zebin, Wu Zemin, Liu Ruixue, Du Qin, Fu Xian, Li Min, Kuang Yongjun, Lin Shen, Wu Jiaxuan, Xie Weiji, Shi Ganggang, Peng Yanqiang, Zheng Fuch |
Impact of Genetic Variants in ABCG2, NR1I2 and UGT1A1 on the Pharmacokinetics of Dolutegravir in Children. Journal of acquired immune deficiency syndromes (1999) 2024 1 . Stephen A Spector, Sean S Brummel, Audrey Chang, Andrew Wiznia, Theodore D Ruel, Edward P Acosta, |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: